Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM for ALS (SHED-CAH2023)

NCT06608719 · clinicaltrials.gov ↗

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL: The study drug is SHED-CM manufactured by U-Factor

Sponsor

Hitonowa Medical